Issuer: Mainz Biomed N.V. / Key word (s): Miscellaneous Mainz Biomed and GANZIMMUN Announce Launch of Enhanced ColoAlert Colorectal Cancer Screening Ahead of Awareness Month 11.02.2025 / 14:01 ...
First introduced by Mainz Biomed in mid-2024, the enhanced ColoAlert features state-of-the-art advancements, including a proprietary DNA stabilizing buffer, to deliver accurate results even with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback